Cargando…
Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating and fatal disease and characterized by increased deposition of extracellular matrix proteins and scar formation in the lung, resulting from alveolar epithelial damage and accumulation of inflammatory cells. Evidence suggests that Caveolin-1 (Cav-1...
Autores principales: | Lin, Xin, Barravecchia, Michael, Matthew Kottmann, R., Sime, Patricia, Dean, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928213/ https://www.ncbi.nlm.nih.gov/pubmed/31873099 http://dx.doi.org/10.1038/s41598-019-55819-y |
Ejemplares similares
-
Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol
por: Judge, Jennifer L., et al.
Publicado: (2018) -
The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
por: Kulkarni, Ajit A., et al.
Publicado: (2013) -
Sodium Houttuyfonate Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice
por: Shen, Yun-hui, et al.
Publicado: (2021) -
Interleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis
por: Liang, Minrui, et al.
Publicado: (2013) -
Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Zhu, Tao, et al.
Publicado: (2013)